Literature DB >> 22534546

Prognostic factors of rectal cancer patients with lateral pelvic lymph node metastasis.

Shin Fujita1, Seiichiro Yamamoto, Takayuki Akasu, Yoshihiro Moriya.   

Abstract

BACKGROUND/AIMS: We examined the clinicopathological characteristics of rectal cancer patients with lateral pelvic lymph node (LPLN) metastasis in order to clarify their associated prognostic factors.
METHODOLOGY: A total of 91 rectal cancer patients with LPLN metastasis who underwent curative resection at the National Cancer Center Hospital between 1985 and 2004 were reviewed.
RESULTS: The five-year overall survival rate and disease-free survival rate of the studied patient were 39% and 27%, respectively. Univariate analysis showed that tumor differentiation, lymphatic invasion, venous invasion, mesenteric lymph node status and LPLN status were significant prognostic factors. Multivariate analysis showed that tumor differentiation, mesenteric lymph node status and LPLN status were significant prognostic factors. Among 15 patients with LPLN metastasis and without mesenteric lymph node metastasis, 11 patients (73.3%) with one or two LPLN metastases survived more than five years. Among 12 patients with four or more LPLN metastases, two(16.7%) survived more than five years.
CONCLUSIONS: Tumor differentiation, mesenteric lymph node status and LPLN status are significant prognostic factors of patients with LPLN metastasis. Because some patients with LPLN metastasis survive for a long period, LPLN dissection should be considered for them.

Entities:  

Mesh:

Year:  2012        PMID: 22534546     DOI: 10.5754/hge12153

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

1.  Incidence and Predictive Model for Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer.

Authors:  Kapil Dev; K V Veerenderkumar; Swamyvelu Krishnamurthy
Journal:  Indian J Surg Oncol       Date:  2018-02-04

2.  Impact of Lateral Pelvic Lymph Node Dissection on the Survival of Patients with T3 and T4 Low Rectal Cancer.

Authors:  Heita Ozawa; Kenjiro Kotake; Miki Hosaka; Akira Hirata; Kenichi Sugihara
Journal:  World J Surg       Date:  2016-06       Impact factor: 3.352

3.  Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases.

Authors:  Toshiya Nagasaki; Takashi Akiyoshi; Yoshiya Fujimoto; Tsuyoshi Konishi; Satoshi Nagayama; Yosuke Fukunaga; Masashi Ueno
Journal:  World J Surg       Date:  2017-03       Impact factor: 3.352

4.  Functional outcomes after lateral pelvic lymph node dissection for rectal cancer: a systematic review and meta-analysis.

Authors:  Benjamin I Cribb; Joseph Kong; Jacob McCormick; Satish K Warrier; Alexander G Heriot
Journal:  Int J Colorectal Dis       Date:  2021-11-30       Impact factor: 2.571

5.  Incidence and prognosis of lower rectal cancer with limited extramesorectal lymph node metastasis.

Authors:  Shin Fujita
Journal:  Int J Colorectal Dis       Date:  2014-06-29       Impact factor: 2.571

6.  Clinical Significance of Extramural Tumor Deposits in the Lateral Pelvic Lymph Node Area in Low Rectal Cancer: A Retrospective Study at Two Institutions.

Authors:  Ryoma Yagi; Yoshifumi Shimada; Hitoshi Kameyama; Yosuke Tajima; Takuma Okamura; Jun Sakata; Takashi Kobayashi; Shin-Ichi Kosugi; Toshifumi Wakai; Hitoshi Nogami; Satoshi Maruyama; Yasumasa Takii; Takashi Kawasaki; Kei-Ichi Honma
Journal:  Ann Surg Oncol       Date:  2016-07-08       Impact factor: 5.344

Review 7.  Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West?

Authors:  Jaime Otero de Pablos; Julio Mayol
Journal:  Front Surg       Date:  2020-01-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.